-
Signature
-
/s/ Allison Blais, as attorney-in-fact
-
Stock symbol
-
ADBE
-
Transactions as of
-
Dec 15, 2023
-
Transactions value $
-
-$305,906
-
Form type
-
4
-
Date filed
-
12/19/2023, 06:02 PM
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
ADBE |
Common Stock |
Options Exercise |
$0 |
+62 |
+1.53% |
$0.00 |
4.12K |
Dec 15, 2023 |
Direct |
|
| transaction |
ADBE |
Common Stock |
Tax liability |
-$17.5K |
-30 |
-0.73% |
$584.68 |
4.09K |
Dec 15, 2023 |
Direct |
F1 |
| transaction |
ADBE |
Common Stock |
Options Exercise |
$0 |
+458 |
+11.21% |
$0.00 |
4.54K |
Dec 15, 2023 |
Direct |
|
| transaction |
ADBE |
Common Stock |
Tax liability |
-$133K |
-227 |
-4.99% |
$584.68 |
4.32K |
Dec 15, 2023 |
Direct |
F1 |
| transaction |
ADBE |
Common Stock |
Sale |
-$156K |
-263 |
-6.09% |
$591.80 |
4.05K |
Dec 18, 2023 |
Direct |
F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
ADBE |
Restricted Stock Units |
Options Exercise |
$0 |
-458 |
-16.65% |
$0.00 |
2.29K |
Dec 15, 2023 |
Common Stock |
458 |
$0.00 |
Direct |
F3 |
| transaction |
ADBE |
Restricted Stock Units |
Options Exercise |
$0 |
-62 |
-16.67% |
$0.00 |
310 |
Dec 15, 2023 |
Common Stock |
62 |
$0.00 |
Direct |
F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: